OOIR: Observatory of International Research

Papers

(The median citation count of Seminars in Radiation Oncology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
The seemingly contradictory roles of radiation as focal to systemic therapy in hematologic malignancies	56
Global Workforce and Access: Demand, Education, Quality	39
Extremity and Truncal Soft Tissue Sarcoma: Risk Assessment and Multidisciplinary Management	38
Rectal Cancer MRI Guided Radiotherapy: A Practical Review for the Physician	34
The Quality Assurance of a 1.5 T MR-Linac	32
Spatially Fractionated Radiotherapy in the Era of Immunotherapy	32
Artificial Intelligence for Radiation Oncology Applications Using Public Datasets	30
Pushing the Envelope: The Role of Radiation Therapy in Non-muscle-Invasive Bladder Cancer	29
Debate 3: Oligometastatic Hormone Sensitive Prostate Cancer Management: Systemic Therapy Approach	27
Artificial Intelligence for Outcome Modeling in Radiotherapy	27
Are We Ready for Life in the Fast Lane? A Critical Review of Preoperative Hypofractionated Radiotherapy for Localized Soft Tissue Sarcoma	24
The Role of Radiation Therapy for Palliation of Hematologic Malignancies	23
[18F]FDG-PET-Based Personalized Radiotherapy Dose Prescription	22
How Small Can We Go? Partial Bladder Radiation Therapy and Brachytherapy	21
Integrating the Patient's Voice in Toxicity Reporting and Treatment Decisions for Breast Radiotherapy	20
Novel biomarkers for guiding treatment for prostate cancer	19
Radiation Therapy for Painful Bone Metastases: Fractionation, Recalcification, and Symptom Control	19
Radiotherapy for Other Nonmalignant Diseases	18
The Role of Radiotherapy in Lymphoma Patients Undergoing CAR T Therapy: Past, Present, and Future	18
Introduction: Personalization of Cancer Care for Older Adults	18
Novel Survivorship Paradigms in Head/Neck Cancer	16
Uncertainty Assessment for Deep Learning Radiotherapy Applications	15
Intrafraction Motion Management With MR-Guided Radiation Therapy	15
Histology Specific Molecular Biomarkers: Ushering in a New Era of Precision Radiation Oncology	15
Normal Tissue Toxicity Prediction: Clinical Translation on the Horizon	15

Radiotherapy Combined with Intralesional Immunostimulatory Agents for Soft Tissue Sarcomas	13
Targeting Noncanonical Regulators of the DNA Damage Response to Selectively Overcome Cancer Radiation Resistance	13
De-escalation of Adjuvant Therapy in Operatively Managed HPV Associated Oropharyngeal Carcinoma: Current Status and Future Directions	13
Myths About Bladder Preservation in Muscle-Invasive Bladder Cancer	13
Advances in Automated Treatment Planning	12
Optimizing Informed Consent in Cancer Clinical Trials	12
The Many Faces of Muscle-Invasive Bladder Cancer: Histopathological and Molecular Characterization	12
Reirradiation for Locally Recurrent Head and Neck Cancer: State-of-the-Art and Future Directions	12
Driving Precision Medicine in Pancreatic Cancer With Molecular Genetics	12
Periarticular Soft Tissue Disorders: Enthesopathies, Tendinopathies, and Bursitis—Pathophysiology and Radiotherapeutic Approaches	12
Safe Hypofractionation Amid Diverse Technologies: Using Teamwork to Manage the Complexity	11
Advancing Prostate Cancer Treatment: A Review of CT and MR-Guided Online Adaptive Radiotherapy Techniques	11
Innovations in Physics, Biology and Clinical Translation of Spatially Fractionated and FLASH Radiotherapy	11
Immunotherapy With Curative Intent Radiotherapy for Patients With Cancers of the Head and Neck	10
Radiation Sensitivity: The Rise of Predictive Patient-Derived Cancer Models	10
Bladder Preservation for Muscle-Invasive Bladder Cancer With Variant Histology	10
Advances and Challenges in Conducting Clinical Trials With Proton Beam Therapy	10
Optimizing GRID and Lattice Spatially Fractionated Radiation Therapy: Innovative Strategies for Radioresistant and Bulky Tumor Management	10
Hypofractionated Radiation Therapy in the Definitive Management of Head and Neck Cancer	10
The Role of Radiotherapy in Hematologic Malignancies in Children, Adolescents, and Young Adults	10
MRI-Guided Radiation Therapy—An Emerging and Disruptive Process of Care: Healthcare Economic and Policy Considerations	10
Early-stage Breast Cancer: Tailored External Beam Fractionation Approaches for Treatment of the Whole or Partial Breast	10
The Use of Particle Therapy in Prostate Cancer	9
Opportunity in Complexity: Harnessing Molecular Biomarkers and Liquid Biopsies for Personalized Sarcoma Care	9
Emerging Systemic Therapy Considerations for Pancreatic Cancer	9
Brain Metastases: Is There Still a Role for Whole-Brain Radiation Therapy?	9
Radiotherapy Dose in Patients Receiving Immunotherapy	8
The History and Future of Multidisciplinary Cancer Care	8
Biological Effects of Low-Dose Radiation Therapy: From Mechanistic Aspects to Translational Approaches and Challenges	8
The Effects of Radiation Dose Heterogeneity on the Tumor Microenvironment and Anti-Tumor Immunity	8
130 Years of Radiotherapy for Nonmalignant Diseases: A Historical Overview	8
Democratizing FLASH Radiotherapy	8
The Use of MR-Guided Radiation Therapy for Head and Neck Cancer and Recommended Reporting Guidance	8
Advancing Towards Personalized Prescription of Radiotherapy Dose	8
Theranostics and Patient-Specific Dosimetry	8
Optimizing Radiation Therapy for Localized Prostate Cancer: Exploring Synergies With Androgen Deprivation Therapy and Novel Systemic Agents	8
Green Horizons in Oncology: A Blueprint for Environmentally Sustainable Radiation Therapy Facilities	8
Hypofractionation in Older Adults With Glioblastoma	8
Bystander Effects in Spatially Fractionated Radiation Therapy: From Molecule To Organism To Clinical Implications	7
Selection and Prejudice: Addressing Clinical Trial Disparities With a Review of Current Shortcomings and Future Directions	7
Radiation Therapy for Non-Malignant Central Nervous System Tumors, Disorders, and Illnesses — Current Applications and Future Directions	7
Lessons and Opportunities for Biomarker-Driven Radiation Personalization in Head and Neck Cancer	7
Towards Data Driven RT Prescription: Integrating Genomics into RT Clinical Practice	7
Integration of Radiation and Reconstruction After Mastectomy	6
Hypoxia-Targeted Dose Painting in Radiotherapy	6
Chromosome Missegregation as a Modulator of Radiation Sensitivity	6
The Future of Education in Radiation Oncology	6
Personalization of Radiation Therapy in the Primary Treatment of Malignant Epidural Spinal Cord Compression (MESCC)	6
Modern Treatment Delivery of Radiotherapy for Lymphomas and Leukemias: Making Every Gy Count	6
Corrigendum to “The Use of MR-Guided Radiation Therapy for Head and Neck Cancer and Recommended Reporting Guidance” Seminars in Radiation Oncology Volume 34 (2024) 69-83	6

Radiation-Therapy Related Salivary Dysfunction	6
MRI-Guided Adaptive Radiation Therapy	6
De-escalated Management of HPV-positive Oropharyngeal Carcinoma: Improving Outcomes with Personalized Approaches	6
Managing Patients with Head and Neck Cancer and Advanced Age or Comorbidities	6
Debate 1: Radical Prostatectomy For the Right Patient With High-Risk Prostate Cancer	6
Exclusion of Older Adults from Cancer Clinical Trials: Review of the Literature and Future Recommendations	5
Contemporary Advances, Evidence, and Considerations in Preoperative Therapy for Pancreatic Ductal Adenocarcinoma	5
Editorial	5
Clinical Applications of Quantitative Imaging and Artificial Intelligence for Pancreatic Cancer	5
Future of Multidisciplinary Team in the Context of Adaptive Therapy	5
MRgRT Quality Assurance for a Low-Field MR-Linac	5
Harnessing the DNA Repair Pathway in Breast Cancer: Germline Mutations/Polymorphisms in Breast Radiation	5
The Use of MR-Guided Radiation Therapy for Liver Cancer	5
The Biological Process of Aging and the Impact of Ionizing Radiation	5
The Peaks and Valleys of Photon Versus Proton Spatially Fractionated Radiotherapy	5
Quality and Quantity: Dual Benefits of Ablative Radiation in Oligometastatic Pancreatic Cancer	5
Radiation Therapy in the Management of Adrenal Metastases	5
Oncometabolites as Regulators of DNA Damage Response and Repair	5
Oral Mucositis in Head and Neck Cancer Patients	4
Artificial Intelligence for Image Registration in Radiation Oncology	4
Advancing the Collaboration Between Imaging and Radiation Oncology	4
Emerging Technologies in Mitigating the Risks of Cardiac Toxicity From Breast Radiotherapy	4
The Future of Safety and Quality in Radiation Oncology	4
Quality Assurance for AI-Based Applications in Radiation Therapy	4
Standardization of Artificial Intelligence Development in Radiotherapy	4
Exploring the Advantages and Challenges of MR-Guided Radiotherapy in Non–Small-Cell Lung Cancer: Who are the Optimal Candidates?	4
A Partial Tumor Irradiation Approach for Complex Bulky Disease	4
Radiotherapy for High-Risk Prostate Cancer	4
Radiation Therapy for Benign Diseases and Premalignant Conditions	3
The contemporary spectrum of radiotherapy for hematologic malignancies involving the central nervous system: From focal therapy to craniospinal	3
Functional Radiotherapy for Non-Malignant Diseases: The Potential of Ionizing Radiation Beyond Cancer Treatment	3
Debate 2: Primary Localized Prostate Cancer: The Case for Whole-Gland Brachytherapy Boost	3
The Role of Ablative Radiotherapy in Older Adults With Limited Metastatic Disease	3
Recognizing Frailty in Radiation Oncology Clinical Practice: Current Evidence and Future Directions	3
Radiation Therapy in Node-Positive Prostate Cancer: Current Evidence and Future Directions	3
MRI-Guided Radiotherapy for Prostate Cancer: Seeing is Believing	3
The Use of Proton and Carbon Ion Radiation Therapy for Sarcomas	3
Radiopharmaceuticals in Prostate Cancer: General Considerations and Utility in Combination With EBRT	3
Targeting Non-homologous and Alternative End Joining Repair to Enhance Cancer Radiosensitivity	3
Genetic and Carcinogenic Risks of Radiotherapy for Nonmalignant Diseases	3
Elective Regional Nodal Irradiation in Prostate Cancer	3
Unraveling the Myth of Radiation Resistance in Soft Tissue Sarcomas	3
Advanced Stage Hodgkin and Diffuse Large B-Cell Lymphomas: Is There Still a Role for Consolidation Radiotherapy in the PET Era?	3
Translating Between Radiation Dose and Late Toxicity for Lymphoma Survivors: Implications on Toxicity Counseling and Survivorship	3
Progress in Retroperitoneal Sarcoma Management: Surgical and Radiotherapy Approaches	3